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Abstract 
The Escherichia coli (E. coli) Ffh protein is homologous to the 54kDa subunit of the eukaryotic signal recognition particle. We have 
examined an intrinsic GTPase activity of this protein and have created mutations in one sequence motif (GXXXXGK) of the putative 
GTP binding site. When glycine-112 was changed to valine (Ffh-G112V), Vm~ x was reduced to only 4% of the wildtype level. On the 
other hand, when glutamine-109 was altered to glycine (Ffh-QI09G), the major effect was a 50-fold increase in K m. These results show 
that the residues Q- 109 and G- l 12 are essential for the binding and hydrolysis of GTP and that they are part of a catalytic site structurally 
related to that of many other GTPase proteins. 
Expression of the mutant protein Ffh-G112V in E. coli was highly toxic in the presence of the wildtype protein. In contrast, genetic 
complementation experiments showed that a viable strain could be constructed where the Ffh-Q109G mutant protein replaced wildtype 
Ffh. However, expression of the mutant protein had a negative ffect on growth rate at 30 ° C and resulted in elongated cells. These results 
demonstrate hat the GTPase activity of the Fill protein is required for proper function of the protein in vivo. 
Kevwords: Srp: Signal recognitioa; Gtpase; Mutant 
1. Introduction 
In eukaryotic ells the signal recognition particle (SRP) 
is involved in the transport of secretory protein to the 
endoplasmatic reticulum (ER) (for reviews see Refs. [1,2]). 
The SRP recognizes a nascent signal sequence presented at 
the ribosome. The SRP/r ibosome complex is then trans- 
ported to the ER where it binds to the SRP receptor. The 
SRP is composed of an RNA molecule (SRP RNA) and 
six different polypeptides. The 54kDa subunit of SRP 
(SRP54) has at least two distinct structural domains [3,4]. 
The C-terminal M-domain has binding sites for both the 
signal sequence and SRP RNA [5-9] and the G-domain 
has sequence lements corresponding to a canonical GTP- 
binding site. Also the SRP receptor subunits a and fl (68- 
and 30kDa, respectively) are GTP binding proteins [10, I 1]. 
The GTP binding site of the SR a subunit is important for 
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protein translocation across the ER [12]. Furthermore, there 
is recent evidence that a GTPase activity of the SRP54 
protein is critical during initiation of translocation. A 
model has been presented by Miller et al. [10,13] to 
describe the role of GTP binding and hydrolysis by the 
SRP54 protein. According to this model, the protein first 
binds to the signal sequence and in this state SRP54 is in a 
nucleotide-free form. The subsequent interaction with the 
SRP receptor increases the affinity of SRP54 for GTP and 
the affinity for the bound signal sequence is reduced. 
Finally, receptor-stimulated hydrolysis of GTP by SRP54 
allows SRP to dissociate from its receptor. 
An SRP-dependent mechanism for protein export has 
also been described in prokaryotes. Proteins homologous 
to eukaryotic SRP54 have been identified in Escherichia 
coli (E. coli) [3,4,14,15], M. mycoides [16], B. subtilis 
[ 17] and in the A. thaliana chloroplast [ 18]. The E. coli 
protein, denoted Ffh (f i fty-four homolog) or P48, is 
essential for viability [19]. It is part of an SRP-like particle 
in complex with 4.5S RNA [20-23]. This RNA has a 
structural domain in common with mammalian SRP RNA 
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and related RNAs have been found in a number of bacte- 
rial species [24,25]. The very simple prokaryote My- 
coplasma mycoides also contains an SRP-related complex 
[16,26]. Previously we showed that the SRP54 homologue 
of this complex has a significant intrinsic GTPase activity 
[27]. 
In order to elucidate the physiological role of the 
GTPase activity of bacterial SRP54 proteins, we have in 
the present work examined the E. coli Ffh protein. We 
constructed mutant Ffh proteins that are defective in GT- 
Pase activity. We studied the phenotype of cells that 
express mutant proteins, both in the absence and presence 
of the wildtype chromosomal copy of the ffh gene. The 
results show that the GTPase activity is indeed critical for 
the function of the protein in vivo and possible mecha- 
nisms involving the GTPase activity are discussed in rela- 
tion to these findings. 
2. Mater ia l s  and  methods  
2.1. Bacterial strains 
The E. coli strains used were BL21 (DE3) pLysS 
(Novagen, F ompT r b m b DE3 pLysS, Cm R) or the 
corresponding strain with pLysE, XL1-Blue (endA1, 
hsdR17(r~-,m~) supE44, thi-1, A, recA1, gyrA96, relA1, 
A(lac), [F', proAB, lacIqZAM15, Tnl0(tetR)]) (Strata- 
gene), and MW100 (Hfr P4X, A-) [28]. The strain GM3819 
(dam::Km), derived from AB1157 [29], was provided by 
Erik Boye, Radiumhospitalet, Oslo, Norway. 
2.2. Site-directed mutagenesis of Ffh and cloning in 
pBR322 
Recombinant DNA techniques were as described [30]. 
The programs of the University of Wisconsin Genetics 
Computer Group were used for analysis of nucleotide and 
amino acid sequences [31]. The plasmid pMWI46 (a pBR 
derivative) has an insert with the ffh gene that corresponds 
to nucleotide positions 1-1700 of the GenEMBL entry 
X01818. The coding sequence is between positions 161- 
1519. The original SalI site at position 1 is replaced by 
EcoRI and an additional BamHI site is at nucleotide 
position 1700. The EcoRI/BamHI fragment of pMW146 
was cloned in M13mpl8 and mutagenesis was as de- 
scribed by Kunkel [32]. Oligonucleotides (obtained from 
Symbicom, Ume~t, Sweden) were 5' CCGGC ACCTC 
CCAGG CCCGC C 3' (Q109G), 5' GTTTT ACCGG 
AACCT TGCAG G 3' (A111S), and 5' GGTTG TTTTA 
ACGGC ACCTT G 3' (G112V). The EcoRI/BamHI frag- 
ments from the M 13 mutant clones as well as the wild-type 
ffh gene (from pMW146) were then cloned in pBR322. 
The resulting pBR constructs were denoted pBR-Ffh-wt 
(wild-type sequence), pBR-Ffh-Q109G, and pBR-Ffh- 
Al l  IS, respectively. The Ml3 fragment with the G112V 
mutation could not be cloned in pBR322. 
2.3. Cloning in pET vectors 
The wild-type and mutant ffh genes from the pBR 
clones above were introduced into the expression vector 
pET3a (Novagen). A PvuI/BamHI fragment containing 
the entire structural gene except the 5' terminal coding 
sequence (20 nt) was joined to pET3a with the aid of a 
NdeI/PvuI synthetic linker composed of the partially 
complementary oligonucleotides 5' TAT GTT TGA TAA 
TTT AAC CGA T 3' and 5' CGG TTA AAT TAT CAA 
ACA 3'. The authentic N-terminal sequence of Ffh was 
thereby restored. In order to facilitate ligation of PvuI 
cleavage products the pBR-Ffh plasmids were purified 
from an E. coli dam strain (GM3819). The G112V mutant 
gene was introduced in pET3a by using the PvuI/BamHI 
fragment from the corresponding M 13 clone. The resulting 
pET constructs were denoted pET3a-Ffh-wt (wild-type 
sequence), pET3a-Ffh-QI09G, pET3a-Ffh-AlllS, and 
pET3a-Ffh-G112V, respectively. The wild-type and mu- 
tant Ffh genes were also cloned in the vector pET15b 
(Novagen) that provides an N-terminal tag (MGSSH HH- 
HHH SSGLV PRGSH M). This sequence contains a 
thrombin cleavage site as well as six consecutive histidines 
for convenient purification on Ni2+-NTA-agarose [33]. 
These plasmids were denoted pET15b-Ffh-wt, pET15b- 
Ffh-Q109G, pET15b-Ffh-A111S, and pET15b-Ffh-G112V. 
2.4. Expression and purification of F, fh wild-type and 
mutant proteins 
The pET15b recombinant vectors were introduced into 
BL21 (DE3) pLysS or BL21 (DE3) pLysE [34,35]. Growth 
of BL21 strains was at 37 ° C in LB medium containing 50 
/xg ampicillin/ml. At OD550 = 0.4, 1 mM IPTG was 
added and growth was continued for 2 h. Growth after 
induction was at 30 ° C as we noted that the yield of protein 
was much higher at this temperature than at 37 ° C. Cells 
were frozen and stored at -20  ° C. Proteins were purified 
by chromatography of cell extracts on Ni2+-NTA-agarose 
as described [16]. The yield was between 4 and 7 mg of 
protein from a 1-1 culture. The protein was stored at 
- 20 ° C at a concentration f approximately 3 mg/ml in a 
buffer containing 50% glycerol [16]. Protein concentration 
was determined using Coomassie Protein Assay Reagent 
(Pierce) [36] and GTPase activity was measured using an 
assay based on the absorption of unreacted GTP to char- 
coal as described [37]. 
2.5. Bacterial genetics 
The phage A439Affh-1 carries the ffh gene where the 
nptI gene from pUC4K has been inserted between codons 
172 and 414 of the ffh structural gene (Fig. 4) (Wikstrtim 
and Berg, manuscript in preparation). The deletion was 
transferred to the chromosome of strain MWI00 that har- 
boured either wild-type or mutant copies of ffh on plasmid 
(pBR-Ffh-wt, pBR-Ffh-Q109G, or pBR-Ffh-A11 IS) as de- 
scribed [37]. To confirm that the deletion of ffh had been 
transferred to the chromosome, the transductants were 
purified from A phages on plates containing 10 mM 
Na-citrate and analyzed by PCR. The oligonucleotides 
used were 5'-AGTCC GTAAC GAACT GGTTG-3' and 
5'-CTCGA TGAAG CGACC GTTG-3' (48K-F1 and S 16-R 
in Fig. 4). The latter oligonucleotide was complementary 
to a sequence downstream of ffh, which is not present in 
the plasmids. Therefore, the PCR reaction will specifically 
amplify chromosomal sequences. 
3. Results 
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3.1. The E. coli Ffh protein has a significant intrinsic 
GTPase activity 
The E. coli Ffh protein was cloned in the vector 
pET15b that provides an N-terminal tag of 20 amino acids 
that includes six consecutive histidines (see Section 2). 
The resulting construct was used to transform the host E. 
coli BL21(DE3) pLysS [34,35]. Upon induction with IPTG 
this system produced the Ffh protein with high yield (data 
not shown) and the protein was purified by chromatograhy 
on Ni2+-NTA-agarose as previously described [27]. 
We found that the Ffh protein had a significant intrinsic 
GTPase activity. For the fltrther examination of this activ- 
ity it was essential that our preparations of Ffh protein 
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Fig. 1. Lineweaver-Burk plot of the Ffh GTPase activity. GTPase activity 
was monitored using conditions described previously for the SRP54 
homolog in Mycoplasma mycoides [27]. The incubation mixture con- 
tained 20 mM Tris-HC1 (pH 7.5), 2 mM MgC12, 10% glycerol, 2 /xM 
GTP, 50 nCi [7-32p]GTP and BSA (0.1 mg/ml)  in a final volume of 20 
/zl and incubation was for 20 min at 37 ° C. 
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Fig. 2. Mutations of residues that are part of the putative GTP binding 
site of E. coli Ffh. The corresponding residues in human Ha/K /N  ras 
p21 [58-60] and E. coli elongation factor Tu [61] are shown for 
comparison. 
were not contaminated to a significant extent with other E. 
coli GTPases. However, such contamination seems un- 
likely as we noted that during further fractionation of the 
Ffh protein all of the GTPase activity consistently copuri- 
fled with the Ffh polypeptide (data not shown). Further- 
more, as a control we fractionated an extract of E. coli 
BL21 pLysS that did not express Ffh and during Ni 2+- 
NTA-agarose chromatography no detectable amounts of 
GTPase activity was eluted with the imidazole gradient 
(data not shown). 
The GTPase activity catalyzed by Ffla was dependent on 
the presence of Mg 2+ and the reaction was stimulated by 
glycerol and was optimal at low ionic strength (data not 
shown). These properties closely resemble those of the 
homologous protein in Mycoplasma mycoides that we 
have previously studied [27]. The kinetic parameters of the 
reaction were estimated from Lineweaver-Burk plots (Fig. 
1). The experimentally determined values of Vma x and K m 
were 1.0 min-1 and 7/zM, respectively. These values are 
similar to those obtained for the mycoplasma protein (0.26 
rain-1 and 3 /zM, respectively) [27]. 
3.2. Mutations in the GTP binding site affect Vm~ x and K m 
differently 
To examine the physiological role of the Ffh GTPase 
activity we constructed mutants in the putative GTP bind- 
ing site (Fig. 2). The mutants were designed from the 
information available on the closely related GTPase pro- 
teins Ras and elongation factor Tu [38]. The three-dimen- 
sional structures of these proteins are known and a number 
of mutants have been studied from a structural and func- 
tional point of view (see also Section 4). We expected the 
changes Q109 ~ G and Gl I2  ~ V to affect the GTPase 
activity. In contrast, the A111 ~ S replacement (included 
as a control) should be a neutral mutation since many 
SRP54 proteins from other organisms have a serine in this 
position [3,4]. 
The mutant proteins were produced as described above 
for the wild-type protein and purified by affinity chro- 
matography on Ni2+-NTA-agarose. Thus, also the mutant 
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proteins had an N-terminal histidine tag and they are 
referred to below as Ffh-A l l lS ,  Ffh-Q109G and Ffh- 
G112V. These proteins were analyzed with respect o the 
kinetic parameters K m and Vm~ x. The changes in positions 
109 and 112 affected the GTPase activity in both K m and 
Vma x as shown in Fig. 3. The Ffh-G112V mutant protein 
had a Vma x which was only 4% of that of the wild-type 
protein. In the Ffh-Q109G mutant there was a moderate 
reduction in Vm~ . On the other hand, K m was increased 
50-fold. The kinetic parameters of Ffh-A11 IS were com- 
parable to that of the wild-type protein and the only 
difference observed was a small change in K m. These 
results show that the residues Q109 and G112 are essential 
components of the GTP binding site. It also demonstrates 
that the active site of the Ffh protein is structurally related 
to that of the Ras and EF-Tu proteins. Interestingly, the 
proteins Ffh-Q109G and Ffh-GI12V had very different 
kinetic properties. We have exploited these findings to 
further analyze the role of the in vivo role of the GTPase 
activity. As shown below, expression of the two mutant 
proteins have different phenotypic effects. 
3.3. Expression of  the mutant protein F fh -G l l2V  in the 
presence of  the wild-type ffh gene is highly toxic 
During the mutagenesis and cloning of fjh constructs 
we noted that the introduction of DNA fragments encoding 
Ffh-Gl l2V without an N-terminal histidine tag into a 
number of different host strains was detrimental to growth. 
For example, when we attempted to clone the ffh gene and 
its mutant derivatives into pBR322 we could only isolate 
plasmids that expressed the Ffh-wt, Ffh-QI09G and Ffh- 
AI 1 IS proteins. We could not isolate plasmids that con- 
tained the G l l2V  mutant gene, indicating that expression 
of Ffh-G112V was harmful to the ceil. Similarly, we failed 
to clone the Ffh-G112V mutant protein in a low copy 
number vector. We also failed to obtain stably transformed 
cells when the structural gene for Ffh-G112V under the 
control of a lac promoter was introduced into a host that 
expressed high levels of the Lac repressor. 
The Ffh-G112V gene could however be cloned success- 
fully in pET vectors where expression of Ffh protein is 
under the control of the T7 RNA polymerase promoter. In 
such constructs equences upstream of the ffh structural 
gene (that presumably contains the native promoter for the 
ffh gene) are replaced by pET3a sequences that include the 
T7 RNA polymerase promoter. Sequence analysis of the 
resulting pET3a plasmids howed that all the mutant genes, 
including G112V, could be integrated in the plasmid when 
the host strain was XL1-Blue (a strain that lacks T7 RNA 
polymerase). The resulting plasmids (pET3a-Ffh-wt, 
pET3a-Ffh-QI09G, pET3a-Ffh-Al l lS and pET3a-Ffh- 
G112V, see under Section 2) were then introduced into 
BL21 (DE3) pLysS, a strain that harbours T7 RNA poly- 
merase. The plasmid pLysS encodes T7 lysozyme which is 
an inhibitor of T7 RNA polymerase and reduces the basal 
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Fig. 3. Kinetic parameters Vma x and K m of wildtype and mutant E. coli 
Ffh proteins. The data were obtained from Lineweaver-Burk plots like in 
Fig. 1. The values plotted are the mean with standard eviation from 
three independent experiments. The actual Vma x values plotted (upper 
panel) are 1+0.09 (wt), 1.2_+0.28 (AlllS), 0.34_+0.09 (QI09G) and 
0.038_+0.022 (Gll2V) and the K m values (/.tM) (lower panel) are 
7.23_+1.68 (wt), 12.5_+0.4 (AII1S), 341-+22 (QI09G) and 41_+14 
(G l 12V). 
polymerase activity [34]. The plasmids pET3a-Ffh-wt, 
pET3a-Ffh-Q109G and pET3a-Ffh-AII1S transformed 
BL21 (DE3) pLysS cells with high efficiency. However, in 
the case of pET3a-Ffh-GII2V the transformation effi- 
ciency was only 2% compared to that of the wild-type 
construct, indicating that expression of this protein is 
detrimental to cell growth. Furthermore, colonies that ap- 
peared overnight on plates with BL21 pLysS cells trans- 
formed with pET3a-Ffh-G112V contained a large propor- 
tion of lyzed cells (that released lysozyme) and therefore 
these transformants could not be grown further. The same 
constructs were also introduced into BL21 pLysE, a strain 
that has a more efficient expression of lysozyme and, 
Table 1 
Complementation of a chromosomal ffh deletion by plasmids carrying 
different alleles of ffh 
Recipient strain Transduction frequency ~
MW 100 (wt) 3.10 -9 
MW 100/pBR-Ffh-wt 2.10 ~ 
MW 100/pBR-Ffh-Q109G 2.10 -5 
MW 100/pBR-Ffh-AI 1IS 2- 10 -5 
a The transduction frequency is expressed as number of K~-transductants 
per added h439Affh-I phage. 
T. Samuelsson et al. / Biochimica et Biophysica Acta 1267 (1995) 83-91 87 
consequently, a lower background of T7 polymerase activ- 
ity. In this case the transformation efficiency of pET3a- 
Ffh-G112V was comparable to that of the other mutant 
plasmids and of the plasmid encoding the wild-type pro- 
tein. However, colonies obtained from transformation with 
pET3a-Ffh-G112V were comparatively small and, like the 
corresponding BL21 pLysS transformants, they contained 
a significant proportion of lyzed cells. 
Taken together all these results clearly indicate a strong 
selection against expression of the Ffh-G112V protein in 
E. coli. 
3.4. Introduction of an N-terminal tag sequence into the 
Ffh-Gll2V protein entirely eliminates its toxic properties 
The expression of the Ffh-Gll2V protein from the 
pET3a plasmid in the host BL21 was highly toxic, as noted 
Table 2 
Effect of temperature 
of ffh on plasmid 
on growth rates of strains carrying different alleles 
Plasmid Specific growth rate (h- i ) a 
30 ° C 37 ° C 
Chromosomal ffh allele 
ffh + A ffh-1 ffh + A ffh- I 
None 0.99 b n.p. 1.81 n.p. 
pBR322 0.97 n.p. 1.73 n.p. 
pBR-Ffh-wt 0.61 0.65 c 1.66 1.54 
pBR-Ffh-Q109G 0.47 0.42 c 1.60 1.60 
pBR-Ffh-A11 IS 0.67 0.66 c 1.60 1.60 
a The growth rate is expressed as k=ln2 /g  where g is the mass 
doubling time in hours. 
b The medium used was LB (Bertani, 1951). n.p. = not possible. 
c For these strains, the growth rate at 30 ° C was determined 7-9 genera- 
tions after a shift from 37 ° C (see Fig. 5), since during extended growth at 
30 ° C, faster-growing derivatives of these strains accumulated. 
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above. In striking contrast, expression from the plasmid 
pET15b-Ffh-Gll2V was not detrimental to cell growth. 
Thus, wild-type and mutant pET15b constructs could all be 
introduced into the strains BL21pLysE and BL21pLysS 
with comparable fficiency. Furthermore, a transformant 
with plasmid pETI 5b-Ffh-G112V could be grown in liquid 
medium as opposed to the strain transformed with the 
corresponding pET3a construct. The pET15b plasmid is 
designed to reduce the background level of T7 RNA 
polymerase to a minimum and contains the T7lac pro- 
moter in addition to a natural promoter and coding se- 
quence for the Lac repressor [35], However, BL21 pLysS 
transformed with pET15b-Ffh-G112V appeared to grow 
rather efficiently even after the induction of T7 RNA 
polymerase (data not shown). Therefore, it seems likely 
that the artificial N-terminal sequence provided by the 
pET15b vector significantly alters the properties of the 
protein so that it is no longer toxic. 
| m 
Fig. 4. Inactivation of the wildtype ffh chromosomal gene. (A) Genetic 
organization of a 5.2 kbp region of phage A439Affh-I used to replace the 
wildtype ffh chromosomal copy with an inactivated copy. NPT, neomycin 
phosphotransferase conferring resistance to kanamycin and neomycin; E, 
EcoRI; S, Sail. The two oligonucleotides 48K-F1 and SI6-R (see Section 
2) were used to analyze mutant colonies with PCR. The 5' ends of these 
oligonucleotides correspond to positions 391 and 1872, respectively, of 
the wildtype sequence (for numbering see EMBL entry X01818). The 
deletion in ffh extends from position 677 to 1399 and the fragment that 
carries the nptl gene is 1252 bp. (B) PCR products. The expected sizes 
are 1482 basepairs from a wildtype ffh gene and 2011 basepairs from the 
inactivated copy marked with nptI. Lanes 1-4, strain MWI00; lanes 
5-7, strain MWI00-AFfh. The plasmids carried by the strains are: None 
(lane 1), pBR/Ffh-wt (lanes 2 and 5), pBR/Ffh-Q109G (lanes 3 and 6) 
and pBR/fFfh-Al 1 IS (lanes 4 and 7). A size marker is in lane 8. 
3.5. The mutant proteins Ffh-QIO9G and Ffh-Al l lS can 
genetically complement a deletion of the wild-type ffh 
chromosomal gene 
To further study the role of the Ffh GTPase activity, it 
was of interest also to examine the phenotype of E. coli 
strains that express a mutant protein and where the wild- 
type ffh gene is inactivated. In particular, we wanted to 
address the question if Ffh-Q109G, with a 50-fold increase 
in K m as compared to the wild-type protein, effectively 
can complement a deletion of the wild-type ffh gene. For 
this problem we made use of the following technology. 
The wild-type copy of ffh on the chromosome can be 
replaced by an inactivated gene copy delivered by a A 
phage, A439Affh-1, if the recipient strain carries additional 
copies of a functional ffh gene on plasmid (Wikstrtim and 
Berg, manuscript in preparation). In phage A439Affh-1, 
the region between codons 172 and 414 of ffh was re- 
placed by the nptI gene that confers resistance to 
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kanamycin and neomycin. The inactivated ffh gene was 
transferred to the chromosome by a recombination event 
involving chromosomal sequences flanking the nptI gene 
in h439Affh-1 and homologous DNA in the chromosome. 
For the transduction experiments we made use of pBR 
derivatives where the ffh gene is under its native promoter 
(pBR-Ffh-wt, pBR-Ffh-Q109G and pBR-F fh -A l l lS ,  see 
Section 2 for further details). 
We showed that the transduction frequency was very 
low when the recipient strain did not carry a functional ffh 
gene (Table 1). This result showed that the ffh gene is 
essential for viability as demonstrated previously by 
Phillips and Silhavy [19]. The plasmids pBR-Ffh-Q109G 
and pBR-Ffh-A111S were both able to complement the ffh 
deletion as demonstrated by the almost 10000-fold differ- 
ence in the transduction frequency between plasmid-con- 
taining and plasmid-free recipient strain (Table 1). The few 
transductants obtained using a plasmid-free strain as recipi- 
ent contain one copy of the wild-type ffh gene and one 
inactivated copy due to exchange of one of two copies in a 
pre-existing duplication (Wikstr~Sm and Berg, manuscript 
in preparation). That h439Affh-1 had replaced the wild- 
type copy of ffh on the chromosome was confirmed by 
PCR (Fig. 4). The strains resulting from complementation 
with the pBR constructs above are referred to in the 
fol lowing as MW100-AFfh /pBR-F fh -wt ,  MW100-  
AF fh /pBR-F fh -Q109G and MW100-AFfh /pBR-F fh -  
A111 S, respectively. 
The complementation experiments demonstrated that 
the Ffh-Q109G protein, which is defective in GTPase 
activity, can compensate for a loss of the wild-type ffh 
gene. Due to the difficulty in isolating a plasmid that 
expresses the Ffh-G112V mutant protein from an E. coli 
promoter, we were unable to test if the corresponding 
mutant gene could complement the chromosomal deletion 
of ffh. However, considering the dominant negative ffect 
of Ffh-G112V, it seems highly unlikely that this protein 
could sustain viability in the absence of wild-type Ffh. 
3.6, Expression of  the mutant protein Ffh-QIO9G impairs 
growth at 30 ° C and gives rise to elongated cells 
To investigate if there was any quantitative difference 
in the ability of the plasmids pBR-Ffh-wt, pBR-Ffh- 
QI09G, and pBR-Ffh-A1 11S to complement the ffh dele- 
tion, the steady-state growth rates of the different MW100- 
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steady-state conditions at 37 ° C in LB supplemented with 50 /xg/ml of 
carbenicillin. The growth was monitored by measuring the optical density at 420 nm on a Zeiss PMQIII spectrophotometer. At a cell density of 
OD420 = 0.5 to 0.6 the cultures were diluted approximately 20-fold in fresh 30 ° C medium (indicated by arrows). When the OD42o again reached 0.5 to 0.6, 
the cultures were diluted once more in 30 ° C medium. (A) MW100/pBR322; (B) MW100-AFfh/pBR-Ffh-wt; (C) MW100-AFfh/pBR-Ffh-QI09G; and 
(D) MW100-AFfh/pBR-Ffh-A11 lS. The same type of result was obtained when the host was strain MW100. Plasmid-free strain MW100 had the same 
growth chacteristics a strain MW100/pBR322 (data not shown). 
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AFfh strains were determined. No significant difference 
was observed in the growth rate at 37°C (Table 2). This 
suggested that the Q109G and A111S substitutions had no 
effects on any essential function of Ffh, at least not when 
Ffh was overproduced from a plasmid. Previously, we 
noted that plasmids that expressed the wild-type ffh gene 
reduced the growth rate dramatically of the wild-type 
strain MW100 at 30°C but not at 37 ° C, indicating that 
cells overproducing ffh are cold-sensitive for growth 
(Eklund and Wikstrtim, unpublished observation). This 
prompted us to examine if the plasmids pBR-Ffh-Q109G 
and pBR-Ffh-A111S also gave rise to the same cold-sensi- 
tivity. The growth rate of a strain where the ffh chromoso- 
Fig. 6. Morphology of cells expressing Ffh wild-type and mutant proteins. 
Cells of MW100-AFfh/pBR-Ffla-wt (A) and MW100-AFfh/pBR-Ffh- 
QI09G (B and C) were grown overnight at 30 ° C on plates containing LB 
with 10 /xg/ml kanamycin and 100 /xg/ml of ampicillin. They were 
then transferred to liquid medium with the same composition and grown 
until OD550 = 0.5. In (A) and (B)cells were photographed using a Nikon 
Diaphot inverted light microscope (400x magnification). For the electron 
micrograph in (C) MW100-AFfh/pBR-Ffh-QI09G cells were treated 
with 2.5% glutaraldehyde, 0.05 M sodium cacodylate (pH 7.2). The cells 
were then postfixed with 0.5% OsO 4 in 0.I M sodium cacodylate for 30 
rain followed by dehydration i  ethanol and infiltration with epoxy resin 
(Agar 100). After curing of the plastic ultrathin sections of embedded E. 
coli pellets were obtained with a Reichert Ultracut ultramicrotome fitted 
with a diamond knife. Sections were contrasted with uranyl acetate and 
lead citrate and examined in a Ze.ss CEM 902 electron microscope. Final 
magnification is 4,500 X. 
mal gene is inactivated and where a Ffh protein is ex- 
pressed from a plasmid was difficult to determine accu- 
rately after extended incubation at 30°C due to the accu- 
mulation of faster-growing derivatives. Therefore, the 
growth rate at 30°C was determined after a shift from 37 
to 30°C (Fig. 5). Interestingly, the growth rate at 30°C of 
strain MW100-AFfh/pBR-Ffh-Q10G was approximately 
35% lower than that of strains MWl00-AFfh/pBR-Ffh-wt 
and MWI00-AFfh/pBR-Ffh-Al l lS (Table 2). We also 
noted that after a shift from 37 to 30 ° C, strains that 
expressed wild-type or mutated Ffh from a plasmid did not 
attain a slow growth until approximately 7 generations 
after the shift (Fig. 5). This suggests that the cold-sensitiv- 
ity observed upon overexpression f ffh is not due to an 
increased synthesis or stability at 30°C of Ffh as such, 
because in that case the new steady-state l vel of Ffh 
would already have been achieved within a generation or 
two after the shift in temperature. 
The slow growth at 30°C of the strain expressing 
Ffh-Q109G suggests that this protein is deficient in its 
ability to fully complement a deletion of the ffh gene 
although it can complement at 37 ° C. The same effect on 
the growth rate was observed with strains that had an 
intact copy of the wild-type ffh gene (Table 2). Thus, the 
Ffh-Q109G protein seems to be dominant over the wild- 
type copy, at least when expressed from a medium-copy- 
number plasmid. 
Further evidence that the mutant protein Ffh-QI09G 
specifically imposes a negative ffect on the growth of E. 
coli at 30 ° C was obtained from microscopical examination 
of cells. Thus, cells of MW100 that contained the wild-type 
or A11 IS mutant ffh genes expressed from a plasmid and 
that have an inactivated copy of the chromosomal ffh gene 
(strains MW100-AFfh/pBR-Ffh-wt  and MW100- 
AFfh/pBR-Ffh-A111 S) had a normal appearance, whereas 
the majority of MW100-AFfh/pBR-Ffh-Q109G cells were 
elongated (Fig. 6). This phenotype presumably reflects a 
block in cell division and is compatible with a role of Ffh 
in targeting of proteins to the membrane. 
4. Discussion 
SRP54 proteins from eukaryotes as well as prokaryotes 
have a well conserved GTP binding domain as judged by 
sequence analysis [39] and there is also experimental evi- 
dence that this site is involved in GTP hydrolysis 
[13,23,27]. In order to study the biological role of this 
activity we have in the present work examined the E. coli 
Ffh protein. We found that in vitro this protein has a 
significant intrinsic GTPase activity. The kinetic parame- 
ters are comparable to those that we have previously 
determined for the mycoplasma protein. The low K m 
reflects a high affinity for the GTP substrate and are 
comparable to the K m data for other related GTPases 
[40,41]. 
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On the other hand, the rate of GTP hydrolysis is 
between one and two orders of magnitude greater than the 
basal level rates measured for Ras [42,43], EF-Tu [40,44] 
and IF-2 [41]. For instance, the rate of GTPase activity 
catalyzed by EF-Tu in the absence of ribosomes is only 
0.125 • 10 -3 s- 1 [44]. It is conceivable that the significant 
basal activity of Ffb is inhibited at some stage in vivo. 
Indeed, Miller et al. [13,23] demonstrated that the presence 
of a signal sequence significantly inhibits GTP hydrolysis 
of the Ffh protein. 
In order to study the physiological importance of the 
GTPase activity of the E. coli Ffh protein we constructed 
mutants in the GTPase site. These substitutions (Q109G, 
A l l lS  and G112V, Fig. 2) were selected on the basis of 
the known three-dimensional structures of the Ras protein 
[45-47] and elongation factor Tu [48,49]. The sequence 
GXXXXGK is highly conserved among GTP binding pro- 
teins [39] and in SRP54 proteins this sequence is 
GLQG(A/S)GK [3,4]. In Ras and EF-Tu these amino 
acids form a loop with many of the residues interacting 
with the phosphates of the guanine nucleotide [38]. Muta- 
tions in these residues affect the GTPase activity. In the 
Ras protein a majority of mutations in G12 reduces the 
GTPase activity and renders the protein oncogenic. For 
instance, in the case of G12V there is an approximately 
10-fold reduction in GTPase rate [50,51]. Similarly, in 
EF-Tu the mutation V20G is associated with an approxi- 
mately 4-fold drop in intrinsic GTPase activity [52,53]. A 
mutation in the residue G15 of the Ras protein seems to 
have a more dramatic effect on its guanine nucleotide 
binding properties [54] as compared to a mutation in GI2. 
Based on these data we would expect hat the substitutions 
Q109G and G112V (Fig. 2) introduced in the E. coli Fill 
protein would significantly affect he activity of the protein 
and the G112V mutation would be the more deleterious. 
Conversely, the substitution A111S would have relatively 
small effects as many other SRP54 proteins from other 
organisms have a serine in this position [3,4]. In the crystal 
structure of EF-Tu and Ras the amino acid residues in this 
position are not as close to the guanine nucleotide as are 
the residues corresponding to Ffh Q 109 and G112 [45-49]. 
Our investigation of the kinetic parameters of the Ffh 
Q109G and GI I2V mutant proteins clearly showed that 
the GTPase activity was affected, supporting the view that 
amino acids in these positions are a part of the site of GTP 
binding or hydrolysis. The alteration in the highly con- 
served G112 residue resulted in a 25-fold drop in Vma ~. In 
contrast, the primary effect of the substitution Q109G was 
a 50-fold increase in K m, indicating a decrease in the 
affinity for the substrate. Considering that the intracellular 
concentration of GTP is approximately 1 mM [55], it is 
possible that the change in K m in the QI09G protein only 
has a minor effect on the activity under in vivo conditions. 
On the other hand, we do not know whether the K m that 
we observe in vitro is an accurate measure of the affinity 
for the GTP substrate in vivo. If GTP binding is the 
primary defect in Ffh-Q109G whereas the Ffh-GII2V 
protein is mainly affected in GTP hydrolysis, both of these 
proteins could be important tools in the further analysis of 
the Fill GTPase cycle. 
Evidence has previously been presented that the ffh 
gene is essential in E. coli [19] and we have obtained 
results to support his conclusion (see also WikstriSm and 
Berg, manuscript in preparation). Furthermore, we find 
that expression of Ffh proteins defective in GTPase activ- 
ity has a negative effect on the growth of E. coli. In 
particular, the Ffh G l l2V mutant protein with the most 
severe deficiency in GTPase activity seems to be a domi- 
nant lethal mutant as we failed to isolate a viable strain 
where this gene product was produced. Genetic comple- 
mentation experiments demonstrated that a viable strain 
could be constructed in which the wild-type chromosomal 
copy of the ffh is inactivated and the Ffh-Q109G mutant 
protein is expressed from a pBR322 plasmid. However, 
this strain had a reduced growth rate at 30 ° C as compared 
to the corresponding strain with the wild-type gene on a 
pBR plasmid. There is a dominant effect of Q109G as the 
same type of growth inhibition is observed in the presence 
of the wild-type chromosomal copy of the ffh gene. We 
also noted that the cells are abnormally elongated, the 
same phenotype observed by Phillips and Silhavy [19] in 
cells depleted of Ffh. Therefore, our data clearly demon- 
strates that the GTPase activity is essential for the biologi- 
cal function of the protein. 
Evidence has recently been presented that a Ffh/4.5S 
RNA complex interacts with FtsY in a GTP-dependent 
manner [23]. Furthermore, FtsY is presumably essential for 
survival [56]. We have in the present work noted that 
expression of Ffh proteins that are defective in GTPase 
activity has a dominant negative effect on growth. It is 
possible that the expression of a mutant Ffh protein inter- 
feres with the normal pathway by forming a dead-end 
complex with FtsY. If the expression of Ffh mutant protein 
is sufficiently high all the molecules of FtsY will be 
inactivated, resulting in a block in an essential pathway. 
The N-terminus of the Ffh protein seems to be neces- 
sary in order for the Ffh-GI12V mutant protein to exert a 
toxic effect. It has previously been suggested that the 
N-terminus forms a separate domain in the SRP54 protein, 
distinct from the G-domain [57]. It is suggested from our 
data that the N-terminus of Ffh is involved in the binding 
of FtsY. As a consequence, an Ffh-G112V mutant protein 
with a modified N-terminus is unable to interact effec- 
tively with the FtsY protein and this would explain why 
expression of such a protein is not toxic. 
It should now be possible to test the importance of the 
Ffh GTPase activity in more detail by studying the role of 
the different effector molecules on the kinetics of gunanine 
nucleotide binding and GTP hydrolysis. We believe that 
the GTPase mutants described in the present work could 
be useful in the further analysis of the mechanisms related 
to Ffh. Thus, the mutants in Vm~ X (GI12V) and K m 
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(Q109G) could be valuable as they could affect different 
steps in a catalytic cycle of  Ffh. Furthermore, it would be 
possible to make use of  ~:he mutant proteins Ffh-Q109G 
and Ffh-G112V in an in vitro system to identify molecules 
that interact with the Ffh protein and that are related to its 
GTPase activity. Finally, the mutants may be used in 
genetic experiments to isolate second-site mutations that 
suppress the defect in GTPase activity. 
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